Navigation Links
GREENGUARD's First Exhibit at HEALTHCARE DESIGN.10 to Help Architects and Designers Specify Healthier Products More Easily and Efficiently
Date:11/2/2010

ATLANTA, Nov. 2, 2010 /PRNewswire-USNewswire/ -- Architects and designers who visit the GREENGUARD Environmental Institute's first-ever HEALTHCARE DESIGN.10 exhibit next week will have the opportunity to learn how low-emitting products and materials can help create healthier, more sustainable healing environments.

(Logo:  http://photos.prnewswire.com/prnh/20090401/DC92292LOGO-b)

(Logo:  http://www.newscom.com/cgi-bin/prnh/20090401/DC92292LOGO-b)

The GREENGUARD exhibit, which draws attention to the potential health hazards of product emissions and invisible indoor air contaminants, will also identify ways that architects and designers can more easily and efficiently specify low-emitting products.

"Given that many people in healthcare environments suffer from weakened immune systems and/or debilitating respiratory conditions, such as asthma, the need to address indoor air quality in healthcare environments is more critical now than ever before," says Paul Bates, market outreach manager for the GREENGUARD Environmental Institute.  "There's no doubt that airborne chemical exposure from product emissions can exacerbate existing health conditions and can even trigger new problems. If the goal of a healthcare environment is to promote healing, it is incumbent upon architects, designers, and facility managers to ensure that the products they use in those environments are low-emitting."

Hazardous airborne chemicals commonly found in healthcare environments include formaldehyde, benzene, methyl methacrylate, and hexane—all of which can off-gas from healthcare-related products. Many are known or suspected carcinogens, reproductive toxins, developmental toxins, and/or physical irritants, and can be particularly harmful to the sick and the elderly.

Products that have achieved GREENGUARD Certification have been independently, scientifically tested to evaluate their chemical emissions and ensure that they meet some of the world's most stringent health-based requirements. As a result, they're recognized in the Green Guide for Healthcare, the healthcare sector's first quantifiable, sustainable design toolkit that integrates environmental and health-based practices into the planning, design, construction, operations and maintenance of healthcare facilities.

"Why risk exposing patients, doctors, nurses, and staff to potentially dangerous contaminants in a place where they're supposed to be healing?" Bates says. "By choosing the right products—those that have been independently assessed for their impact on indoor air quality—you can be certain that the healing environment you're creating is healthier for everyone involved."

To learn more about GREENGUARD Certified products at HEALTHCARE DESIGN.10, visit Booth Number 258. HCD.10 runs Nov. 13 through Nov. 16. For more information, visit www.hcd10.com.

About GREENGUARD Environmental Institute (GEI)

The GREENGUARD Environmental Institute aims to protect human health and improve quality of life by enhancing indoor air quality and reducing people's exposure to chemicals and other pollutants.  As an ISO-IEC Guide 65:1996 accredited, third-party organization, the GREENGUARD Environmental Institute certifies products and materials for low chemical emissions and provides a resource for choosing healthier products and materials for indoor environments.  All certified products must meet stringent chemical emissions standards based on established criteria from key public health agencies. GREENGUARD Certification is broadly recognized and accepted by sustainable building programs and building codes worldwide.  For more information and a complete listing of certified products, visit www.greenguard.org.


'/>"/>
SOURCE GREENGUARD Environmental Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CareFusion Reports First Quarter Fiscal 2011 Results; Reaffirms Fiscal 2011 Financial Guidance
2. Endologix Announces First Clinical Implant of Ventana™ Stent Graft
3. NeurogesX Doses First Patient in Phase 2 Clinical Study of NGX-1998 Liquid Capsaicin Formulation
4. PAREXEL Reports First Quarter Fiscal Year 2011 Financial Results
5. Octapharma Clinical Trial Begins in the U.S. and Germany Treating Hemophilia A Patients with First Recombinant Factor VIII Derived from a Human Cell-Line
6. VIDEO from thenewsmarket.com and Novartis: Novartis drug Afinitor® Approved by FDA as First Medication for Children and Adults With a Benign Brain Tumor Associated With Tuberous Sclerosis
7. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2011
8. VIDEO from thenewsmarket.com and Roche Pharmaceuticals: MabThera Approved in Europe for First Line Maintenance Treatment of Follicular Lymphoma, a Common Type of Blood Cancer
9. CTIA-The Wireless Association® to Host First Wireless Health Pavilion at MEDICA 2010 World Forum for Medicine
10. Apollo Endosurgery Completes First-in-Human Cases With New OverStitch™ Endoscopic Suturing System
11. D3 Launches New Suite of Solutions, including the First Radiation Oncology Clinical Pathways Program, at the ASTRO Annual Meeting, October 31 - November 3, 2010 in San Diego
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Any dentist who has made an implant supported ... Many of them do not even offer this as a ... laboratory costs involved. And those who ARE able to offer ... high cost that the majority of today,s patients would not ... Zadeh , founder of Dental Evolutions Inc. and inventor of ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 Roche ... received 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) ... severe sepsis or septic shock. With this clearance, Roche ... provide a fully integrated solution for sepsis risk assessment ... associated with bacterial infection and PCT levels in blood ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... Oklahoma City, Oklahoma (PRWEB) , ... June 25, ... ... to helping both athletes and non-athletes recover from injury. Recently, he has implemented ... for the Oklahoma City area —Johnson is one of the first doctors to ...
(Date:6/24/2016)... ... , ... June 19, 2016 is World Sickle Cell Observance Day. In an ... of holistic treatments, Serenity Recovery Center of Marne, Michigan, has issued a ... Cell Disease (SCD) is a disorder of the red blood cells, which can cause ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... Vegas, Nevada (PRWEB) , ... June 24, 2016 ... ... Las Vegas client, The Grove Investment Group (TGIG), has initiated cultivation and processing ... Grove, in Las Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of ...
Breaking Medicine News(10 mins):